SEC Tracker
Get the app

Jasper Therapeutics JSPR

Jasper Therapeutics Appoints Herb Cross as Chief Financial Officer

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Jasper Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  2. Macrogenics MGNX public float $74M, Jun 30, 2025
  3. Volitionrx VNRX public float $73M, Jun 30, 2025
  4. XBiotech XBIT public float $77M, Jun 30, 2025
  5. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025